New England Capital Financial Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.3K | Hold |
528
| – | – | 0.02% | 128 |
|
|
2025
Q1 | $38.3K | Hold |
528
| – | – | 0.02% | 129 |
|
|
2024
Q4 | $39.1K | Hold |
528
| – | – | 0.02% | 127 |
|
|
2024
Q3 | $34.8K | Hold |
528
| – | – | 0.02% | 140 |
|
|
2024
Q2 | $48.8K | Hold |
528
| – | – | 0.03% | 109 |
|
|
2024
Q1 | $50.5K | Hold |
528
| – | – | 0.03% | 111 |
|
|
2023
Q4 | $40.3K | Hold |
528
| – | – | 0.02% | 126 |
|
|
2023
Q3 | $36.6K | Hold |
528
| – | – | 0.03% | 124 |
|
|
2023
Q2 | $49.8K | Hold |
528
| – | – | 0.03% | 112 |
|
|
2023
Q1 | $43.7K | Hold |
528
| – | – | 0.03% | 128 |
|
|
2022
Q4 | $41.9K | Buy |
+528
| New | +$41.9K | 0.03% | 135 |
|